FDA Approved: DIGOXIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for DIGOXIN from Hikma Pharmaceuticals USA Inc., resulting in changes to the approved product labeling under NDA 021648.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter
• Heart Failure

Drugs mentioned

• DIGOXIN (Digoxin)

Snippet

SUPPL AP for DIGOXIN (DIGOXIN)